NO991477L - Oralpreparat inneholdende minst en farmas°ytisk aktiv forbindelse i en matriks istand til Õ svelle i et vanlig medium - Google Patents

Oralpreparat inneholdende minst en farmas°ytisk aktiv forbindelse i en matriks istand til Õ svelle i et vanlig medium

Info

Publication number
NO991477L
NO991477L NO991477A NO991477A NO991477L NO 991477 L NO991477 L NO 991477L NO 991477 A NO991477 A NO 991477A NO 991477 A NO991477 A NO 991477A NO 991477 L NO991477 L NO 991477L
Authority
NO
Norway
Prior art keywords
swelling
active compound
pharmaceutically active
preparation containing
oral preparation
Prior art date
Application number
NO991477A
Other languages
English (en)
Other versions
NO991477D0 (no
Inventor
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO991477D0 publication Critical patent/NO991477D0/no
Publication of NO991477L publication Critical patent/NO991477L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO991477A 1996-09-28 1999-03-26 Oralpreparat inneholdende minst en farmas°ytisk aktiv forbindelse i en matriks istand til Õ svelle i et vanlig medium NO991477L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19640062A DE19640062B4 (de) 1996-09-28 1996-09-28 Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
PCT/EP1997/004717 WO1998013028A1 (de) 1996-09-28 1997-08-29 Orale zubereitung, enthaltend in einer in wässrigem medium quellbaren matrix wenigstens einen pharmazeutischen wirkstoff

Publications (2)

Publication Number Publication Date
NO991477D0 NO991477D0 (no) 1999-03-26
NO991477L true NO991477L (no) 1999-03-26

Family

ID=7807265

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991477A NO991477L (no) 1996-09-28 1999-03-26 Oralpreparat inneholdende minst en farmas°ytisk aktiv forbindelse i en matriks istand til Õ svelle i et vanlig medium

Country Status (23)

Country Link
US (1) US6238698B1 (no)
EP (1) EP0946150B1 (no)
JP (1) JP2001504807A (no)
KR (1) KR100493139B1 (no)
CN (1) CN1139378C (no)
AT (1) ATE213933T1 (no)
AU (1) AU724802B2 (no)
CA (1) CA2260845C (no)
CZ (1) CZ291258B6 (no)
DE (2) DE19640062B4 (no)
DK (1) DK0946150T3 (no)
ES (1) ES2174296T3 (no)
HU (1) HU227865B1 (no)
IL (1) IL129171A (no)
MY (1) MY130959A (no)
NO (1) NO991477L (no)
NZ (1) NZ333401A (no)
PL (1) PL188392B1 (no)
PT (1) PT946150E (no)
SI (1) SI0946150T1 (no)
SK (1) SK282709B6 (no)
WO (1) WO1998013028A1 (no)
ZA (1) ZA978625B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
BRPI0615860B8 (pt) 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
US8226967B2 (en) 2008-11-27 2012-07-24 Basf Se Surface active proteins as excipients in solid pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
WO1994002121A1 (en) * 1992-07-24 1994-02-03 Labopharm Inc. Cross-linked polyhydroxylic material for enzymatically controlled drug release
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
DE4341442C2 (de) 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4416926C2 (de) 1994-05-13 2000-01-13 Lohmann Therapie Syst Lts Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Wirkstoffen
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
WO2007095324A1 (en) 2006-02-14 2007-08-23 The Procter & Gamble Company Personal care compositions comprising responsive particles

Also Published As

Publication number Publication date
JP2001504807A (ja) 2001-04-10
WO1998013028A1 (de) 1998-04-02
SI0946150T1 (en) 2002-08-31
HUP9903115A2 (hu) 2000-02-28
EP0946150B1 (de) 2002-03-06
HUP9903115A3 (en) 2000-03-28
DE19640062B4 (de) 2006-04-27
NO991477D0 (no) 1999-03-26
SK38799A3 (en) 2000-03-13
IL129171A (en) 2001-11-25
DK0946150T3 (da) 2002-06-24
CA2260845A1 (en) 1998-04-02
PL332577A1 (en) 1999-09-27
AU724802B2 (en) 2000-09-28
US6238698B1 (en) 2001-05-29
HU227865B1 (en) 2012-05-29
CN1231600A (zh) 1999-10-13
SK282709B6 (sk) 2002-11-06
ATE213933T1 (de) 2002-03-15
PT946150E (pt) 2002-08-30
CA2260845C (en) 2005-11-22
CZ101399A3 (cs) 1999-07-14
CN1139378C (zh) 2004-02-25
PL188392B1 (pl) 2005-01-31
CZ291258B6 (cs) 2003-01-15
NZ333401A (en) 1999-10-28
IL129171A0 (en) 2000-02-17
DE19640062A1 (de) 1998-04-09
EP0946150A1 (de) 1999-10-06
AU4619397A (en) 1998-04-17
KR100493139B1 (ko) 2005-06-02
ZA978625B (en) 1998-03-26
ES2174296T3 (es) 2002-11-01
DE59706576D1 (de) 2002-04-11
KR20010029533A (ko) 2001-04-06
MY130959A (en) 2007-07-31

Similar Documents

Publication Publication Date Title
DE69316715D1 (de) Mehrschichtige Matrixsysteme mit kontrollierter Wirkstoffabgabe
AR002275A1 (es) Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
CA2214033A1 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
ES2182397T3 (es) Comprimido para la liberacion instantanea y prolongada de una o mas substancias activas.
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
MX9706785A (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de la bomba de protones y un agente antiacido o alginato.
DK1037634T3 (da) Oral administrationsform som omfatter en protonpumpeinhibitor (fx pantoprazo)
EP0356382A3 (de) Mehrschichtiges Pflaster
NO991477L (no) Oralpreparat inneholdende minst en farmas°ytisk aktiv forbindelse i en matriks istand til Õ svelle i et vanlig medium
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
NO970610L (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
AR043070A1 (es) Sistema monolitico que contiene una o mas drogas, formado por tres capas con diferentes mecanismos de liberacion
NO20012351L (no) Farmasoytisk sammensetning for modifisert frigjoring av insulinsensibiliserende middel
ATE321540T1 (de) Okklusives transdermales therapeutisches system mit nicht-okklusiver rückschicht
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
AR016350A1 (es) Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos
IT1196190B (it) Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno
AR004330A1 (es) Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
ES2139932T3 (es) Sistema terapeutico percutaneo a base de estradiol con aditivos higroscopicos.
SE9501670D0 (sv) Omläggningsset
WO1996008237A3 (de) Selbstklebendes pflaster zur abgabe von wirkstoff an die umgebung eines trägers
NO981320L (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
EP0974361A4 (en) METHOD OF USING AN ANTI-ACID AGENT AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME
HUP9902681A2 (hu) Térhálósított amilózt és hidroxi-propil-metil-cellulózt tartalmazó hordozóval készült szabályozott felszabadulású tabletta gyógyszerkészítmény